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Abstract Sites of A3 adenosine receptor gene expression have
not been fully explored nor has this gene’s promoter activity
been con¢rmed in vivo. Transgenic mice were generated in which
2.3 kb upstream of the transcriptional start site of the mouse A3
adenosine receptor was coupled to a L-galactosidase reporter
gene. Selective transgene expression was detected in testis and
brain as well as at other sites in which A3 adenosine receptor
message has not been previously reported, including retinal gan-
glion cells and smooth muscle cells of the cerebrospinal vascu-
lature. Our study suggests that this promoter may be useful in
the selective targeting of gene expression to speci¢c tissues.
# 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Adenosine is a natural metabolite that plays a role both in
normal cell physiology and in certain pathological processes.
To date, four adenosine receptors ^ A1, A2a, A2b, and A3 ^
have been cloned [1]. All four are G protein-coupled receptors
that have the capacity to modulate intracellular cAMP levels.
Receptors for adenosine are natural candidates for investigat-
ing the mechanisms through which adenosine in£uences hu-
man physiology and may serve as a tool for speci¢cally tar-
geting adenosine activity.
The most recently cloned adenosine receptor, the A3 adeno-
sine receptor, has been implicated in diverse processes such as
cell growth [2], ischemia/reperfusion injury [3], and modula-
tion of in£ammatory responses [4,5]. There are some discrep-
ancies in published descriptions regarding the tissue distribu-
tion of A3 adenosine receptor message in the rat and the
human [6^12]. In the rat, however, there is considerable evi-
dence for high levels of expression in the testis, with lower
levels in brain, lung, and other tissues.
Transgenic mice are commonly used to analyze the expres-
sion of DNA constructs in vivo, and the bacterial lacZ gene
has been employed frequently to determine spatial and tem-
poral speci¢city of the control of transcription by promoter
elements. A 2.3 kb mouse genomic fragment 5P upstream of
the coding region for the mouse A3 adenosine receptor dem-
onstrates promoter activity in transient transfection studies
[13]. We have generated transgenic mice using a reporter con-
struct composed of this fragment driving the expression of
Escherichia coli lacZ. These mice were analyzed for expression
of lacZ mRNA by reverse transcription-polymerase chain re-
action (RT-PCR), and for L-galactosidase activity by histo-
chemistry. This pro¢le of lacZ expression was compared to
endogenous A3 adenosine receptor mRNA levels, as deter-
mined by in situ hybridization to RNA probes, and by RT-
PCR. Our goal was to determine whether 2.3 kb of the mouse
A3 adenosine receptor promoter could recapitulate A3 adeno-
sine receptor expression in vivo and reveal previously un-
known locations of expression.
2. Materials and methods
2.1. Generation of constructs
All restriction endonucleases were acquired from New England Bio-
labs (Beverly, MA, USA). The pSDKLacZpA and pA3HGH con-
structs have been described previously [13,14]. A BamHI fragment
of the pA3HGH plasmid, containing 2.3 kb of the 5P non-coding
region of the mouse A3 adenosine receptor gene, was inserted up-
stream of the E. coli lacZ coding region of pSDKLacZpA. Proper
orientation of the ligated fragments was con¢rmed by sequencing, and
the resulting plasmid, termed pSA3Z, was puri¢ed by CsCl density
gradient centrifugation.
The pA3INSITU plasmid was generated by cloning a 350 bp PCR
product, derived from exon II of the mouse A3 adenosine receptor
gene, into the pCRII vector, using the pCRII TA Cloning Kit (Invi-
trogen, Carlsbad, CA, USA). Primers (Invitrogen) mA3EX2-1F
(5P-GTT TCC TTT CTG GTG GGG C-3P) and mA3EX2-1R
(5P-GCA CAT TGC GAC ATC TGG TAT C-3P) were used to gen-
erate the insert. Orientation and sequence ¢delity of the ¢nal construct
were con¢rmed by sequencing and the resulting plasmid was puri¢ed
by CsCl density gradient centrifugation.
2.2. Generation of transgenic mice
pSA3Z was digested with KpnI and fractionated by agarose gel
electrophoresis. A 5.5 kb fragment, containing the mouse A3 adeno-
sine receptor promoter, lacZ coding region, and SV40 polyadenyla-
tion signal, was excised from the gel and puri¢ed by electroelution
followed by ethanol precipitation. DNA was resuspended using injec-
tion bu¡er (7.5 mM Tris^HCl, 0.15 mM EDTA, pH 7.4). Injection of
DNA into the pronuclei of fertilized eggs, derived from FVB mice,
was performed at Boston University’s Transgenic Core, as described
previously [14,15]. Incorporation of the transgenic fragment was con-
¢rmed by Southern blotting. The probe used for Southern blotting
was generated by EcoRI and EcoRV digestion of pSA3Z/KpnI DNA
and gel puri¢cation of a 1.9 kb fragment and was speci¢c for the
E. coli lacZ coding region (see Fig. 1).
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2.3. Reverse transcription coupled to the polymerase chain reaction
Animals were anesthetized by inhalation of iso£urane and exsan-
guinated. Tissue was dissected and immediately rinsed in ice-cold
1Uphosphate bu¡ered saline (PBS) and homogenized in Trizol (In-
vitrogen) using a Virtis Handishear handheld homogenizer. RNA was
puri¢ed using the Trizol RNA isolation kit as directed by the manu-
facturer and resuspended in 0.1% diethyl pyrocarbonate treated water
(American Bioanalytical, Natick, MA, USA).
RT-PCR of tissue RNA was performed as described previously [16]
with the following modi¢cations: PCR was carried out in a total
volume of 25 Wl, containing a ¢nal concentration of 1UPCR bu¡er,
1.5 mM MgCl2, 200 WM each dNTP, 0.5 WM each of the two primers
used, and 1 U of Taq DNA Polymerase (Promega, Fitchburg, WI,
USA). For ampli¢cation of glyceraldehyde phosphate dehydrogenase
(GAPDH) message, 1 Wl of reverse transcription was used as template,
whereas 2 Wl of reverse transcription was used as template for ampli-
¢cation of the mouse A3 adenosine receptor message and for ampli-
¢cation of lacZ message. Annealing temperatures of 55‡C for
GAPDH message ampli¢cation, 57‡C for A3 adenosine receptor mes-
sage ampli¢cation, and 59‡C for lacZ message ampli¢cation were
used. Reactions were performed with 30 cycles of ampli¢cation. All
primers were acquired from Invitrogen. Primers used for A3 adeno-
sine receptor message ampli¢cation from mouse tissue were mA31-F
(5P-ACG GAC TGG CTG AAC ATC ACC TAC-3P) and mA31-R
(5P-TGT AAT CCA AAC TGA CCA CGG AAC-3P). Primers used
for A3 adenosine receptor message ampli¢cation from rat tissue were
RATA3-F (5P-TTG CTG TAG ACC GAT ACC TGC GAG-3P) and
RATA3-R (5P-TGA ACT CCC GAC CGT AAA ATG C-3P). Primers
used for lacZ message ampli¢cation were LACZ1-F (5P-CTA TCG
TGC GGT GGT TGA ACT G-3P) and LACZ1-R (5P-CCA GGT
AGC GAA AGC CAT TTT TTG-3P). RT-PCR products were sepa-
rated on a 1.2% agarose gel containing ethidium bromide and visual-
ized under UV light.
2.4. Preparation of mice for L-galactosidase assay and
in situ hybridization
Mice were anesthetized by inhalation of ether and perfused through
a needle in the left ventricle. Mice were perfused with 6 ml of 1UPBS
followed immediately by 24 ml of 2% formaldehyde or a mixture of
4% formaldehyde/0.25% glutaraldehyde (American Bioanalytical) at a
rate of 6 ml/min using a peristaltic pump. Perfusion of ¢xative was
continued for 15 min at 2.75 ml/min, followed by perfusion of 1UPBS
for 10 min. Mice prepared for in situ hybridization analysis were
perfused with 6 ml of 1UPBS followed immediately with 24 ml of
4% formaldehyde at a rate of 6 ml/min. Perfusion of ¢xative was then
continued for 25 min at 2.75 ml/min.
2.5. L-Galactosidase assay and histology
Tissue was dissected from mice and stored in ice-cold 1UPBS prior
to staining for L-galactosidase activity. Individual organs were cut
into 0.5^1 mm thick slices, and stained as described previously [17].
The staining solution contained a ¢nal concentration of 1 mg/ml
5-bromo-4-chloro-3-indolyl-L-D-galactopyranoside (X-gal) or halogen-
ated indolyl-L-D-galactoside (Bluo-gal; Invitrogen). Samples were
incubated at 37‡C for 6^12 h on a rocking platform. All locations
of speci¢c L-galactosidase activity were detected within 6 h of stain-
ing.
Tissue used for para⁄n and plastic histology was dehydrated in a
graded ethanol series. Samples destined for para⁄n sectioning were
cleared with xylenes and embedded with para⁄n in a heated vacuum
oven. Para⁄n blocks were stored at 4‡C and cut at a thickness of
5 Wm. Slides for in situ analysis were stored at 4‡C for less than
1 month. Tissue for electron microscopy was prepared essentially as
described previously, except that staining with contrast reagents was
speci¢cally omitted [18].
2.6. In situ hybridization
The pA3INSITU plasmid was linearized with the restriction en-
zymes EcoRV and HindIII. 35S-labeled sense and antisense RNA
was generated from EcoRV- and HindIII-digested plasmid, respec-
tively. SP6 RNA polymerase (Promega) was used to generate sense
strands, while T7 RNA polymerase (Promega) was used to generate
antisense strands. The expected probe size was 350 bases. In situ hy-
bridization was performed as described previously [15].
3. Results
3.1. Generation of pSA3Z mice
In order to examine promoter activity in vivo, transgenic
mice (pSA3Z) were generated using a transgenic construct
containing 2.3 kb of the 5P £anking region of the mouse A3
adenosine receptor gene coupled to E. coli lacZ (Fig. 1). Four
independent founders were identi¢ed by Southern blot analy-
sis of genomic DNA. Three founder lines (lines #5, #26, and
#33) incorporated a similar number of transgene copies, while
the fourth (line #29) incorporated a signi¢cantly greater num-
ber of transgene copies. pSA3Z mice were not visibly distin-
guishable from wild type littermates, bred normally, and
transmitted the transgene in a Mendelian fashion. RT-PCR
analysis of RNA derived from testis, brain, spleen, kidney,
heart, lung, uterus, and skeletal muscle of mice from each
transgenic line showed no signi¢cant changes in endogenous
A3 adenosine receptor mRNA level compared to wild type
controls (data not shown).
3.2. Distribution of A3 adenosine receptor message in
mouse testis and L-galactosidase activity in testis and
retina of transgenic mice
Testis is the most abundant source of A3 adenosine recep-
tor mRNA in the mouse. We used the testis of our transgenic
pSA3Z mice for a detailed comparison of the pro¢le of
L-galactosidase activity, driven by the A3 receptor promoter,
with the pattern of endogenous A3 adenosine receptor mRNA
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Fig. 1. Generation of transgenic mice carrying pSA3Z. A: Sche-
matic of the KpnI digestion of pSA3Z showing the relative position
and size of the BamHI fragment of the mouse A3 adenosine recep-
tor promoter, the E. coli lacZ coding region, and the SV40 polyA
signal. The region corresponding to the probe used for Southern
analysis is indicated. B: Southern analysis of mouse tail DNA,
digested with EcoRI and EcoRV, from o¡spring of transgenic mice
of the four independent lines generated. Approximately 10 Wg of
genomic DNA was loaded in each lane; the control lane contained
50 pg of an EcoRI/EcoRV digestion of the construct used for gener-
ating the mice. The arrow points to the expected 1.9 kb product.
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Fig. 2. Endogenous A3 adenosine receptor message and L-galactosidase activity in testis and retina of transgenic mice. A: 16 Wm cryosections
of wild type mouse testis were subjected to in situ hybridization using a radiolabeled sense or antisense probe derived from the second exon of
the mouse A3 adenosine receptor gene. Sections were lightly stained with hematoxylin and eosin and visualized for speci¢c hybridization of
probe. B: Testes from wild type, #26, and #5 line mice were stained 6 h for L-galactosidase activity. 5 Wm para⁄n sections, counterstained
with nuclear fast red, are shown. C,D: Eyes from wild type, #26, and #5 line mice were dissected and stained 6 h for L-galactosidase activity.
C: After staining, retina was dissected and small segments examined in whole-mount preparations at 40U magni¢cation. D: 5 Wm para⁄n
cross-sections of retina, counterstained with nuclear fast red, are shown. Arrows indicate locations of L-galactosidase activity.
Fig. 3. L-Galactosidase activity in the cerebrospinal vasculature of transgenic mice. Spinal cord and brain of wild type, #26, and #5 line mice
were stained for L-galactosidase activity with X-gal (A,B) or Bluo-gal (C). A: Ventral aspect of the caudal spinal cord of wild type, #26, and
#5 line mice. The boxed area is magni¢ed in the lower panel. Arrows indicate the location of the anterior spinal artery in control mice.
B: Whole mount of the basilar artery of a #26 line transgenic mouse at 40U magni¢cation. C: Electron microscopy of plastic sections of a
#26 line anterior spinal artery stained for L-galactosidase activity. Arrows indicate location of deposits of L-galactosidase product. LUM, lumen
of artery; EC, endothelial cell ; SMN, smooth muscle cell nucleus; SMC, smooth muscle cell cytoplasm; AD, adventitia.
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expression. We found that endogenous A3 mRNA was highly
expressed and widely distributed within the seminiferous tu-
bules (Fig. 2A). This distribution is consistent with expression
of A3 adenosine receptor mRNA in developing germ cells. A3
mRNA was not detected in the periphery or lumen of the
tubule, or in other parts of the testis.
Testes of wild type and pSA3Z mice were analyzed for
expression of the lacZ gene product by RT-PCR, using trans-
gene-speci¢c primers, and histochemically by incubation with
X-gal, a substrate which is converted ultimately into a deep
blue precipitate by L-galactosidase activity. RT-PCR indicated
transgene expression in the testis in all four lines (not shown).
Gross inspection of histochemical preparations revealed spe-
ci¢c L-galactosidase activity in the testis in two of the trans-
genic lines (#26s#5); high background staining may have
obscured lower-level transgene expression in the other two
lines. As described below, histochemical staining was generally
more intense for the #26 line in all of the tissues where the
transgene was active. As expected from various other studies,
the level of transgene expression did not correlate with trans-
gene copy number in each line. Testicular L-galactosidase ac-
tivity was distributed in a periluminal fashion, with increasing
intensity towards the center of the seminiferous tubule (Fig.
2B). No speci¢c L-galactosidase activity was detected at the
periphery of the seminiferous tubule or in other parts of the
testis.
Analysis of di¡erent organs revealed speci¢c L-galactosidase
activity in the retina in three transgenic lines (#5, #26, and
#29). L-Galactosidase staining was localized to a subset of
retinal ganglion cells that was evenly distributed within the
retina (Fig. 2C,D).
3.3. L-Galactosidase activity in cerebrospinal vasculature
of transgenic mice
Speci¢c L-galactosidase activity was detected in the cerebro-
spinal vasculature of two transgenic lines (Fig. 3A). A seg-
ment of basilar artery was stained for L-galactosidase activity
and examined at low magni¢cation, under a light microscope.
The pro¢le of L-galactosidase staining activity in this artery
was consistent with that of vascular smooth muscle cells
(VSMC), although only a subset of these cells was stained
(Fig. 3B). Speci¢c staining was also observed in the anterior
spinal artery, the vasculature on the ventral surface of the
cerebral hemispheres and brainstem, and in vasculature within
the brainstem (Fig. 3A,B, and data not shown). To con¢rm
that cells staining for L-galactosidase activity were, in fact,
VSMC, we stained anterior spinal artery of mice of line #26
with Bluo-gal, a substrate for L-galactosidase that generates
an electron-dense precipitate. Examination at the electron mi-
croscopic level demonstrated speci¢c deposition of precipitate
in a subset of VSMC (Fig. 3C). No precipitate could be de-
tected in the adventitial or endothelial cell layers of the vessel.
No speci¢c L-galactosidase activity could be observed histo-
chemically in other vessels, including aorta, carotid arteries,
and iliac arteries (data not shown).
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Fig. 4. Endogenous A3 adenosine receptor message in cerebrospinal
vasculature and retina. RNA generated from tissues of female
Sprague^Dawley rats was reverse-transcribed (+ and 3 indicate the
presence or absence of reverse transcriptase during the incubation).
PCR was subsequently performed with primers speci¢c for endoge-
nous rat A3 adenosine receptor message and for GAPDH message.
Fig. 5. L-Galactosidase activity in brains of transgenic mice. Sagittal brain slices from wild type, #26, and #5 line mice were stained for
L-galactosidase activity. Shown are two representative sections each, at di¡erent levels, from #26 and #5 line mice. In the upper panel for the
#26 line, the white arrows demarcate the position of scattered L-galactosidase-positive neurons in the cerebral cortex. In the lower panel, the
black arrow marks the position of the interpeduncular nucleus, contiguous with the similarly positive habenulo-interpeduncular tract, which ap-
pears as a dark blue diagonal stripe. The white arrowheads show the position of thalamic staining. In the lower panel for the #5 line, the white
triangles show the position of the superior colliculus, light-blue stained, and the black arrowhead marks the position of the thalamic staining
visible at this level. Detailed examination at higher magni¢cation, and L-galactosidase histochemistry on cryostat sections (not shown) con-
¢rmed that the X-gal reaction product in thalamus and cortex, like that in the retina (Fig. 2), was present in neurons.
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3.4. Expression of endogenous A3 adenosine receptor in
cerebrospinal vasculature and retina
To date, there have been no reports of A3 adenosine recep-
tor expression in the cerebrospinal vasculature or retina. In
light of observed L-galactosidase activity in these tissues in
pSA3Z mice, we sought to determine if endogenous A3
adenosine receptor message could be detected in these tissues.
In situ hybridization of mouse retina and cerebrospinal vas-
culature, using a probe derived from the second exon of the
mouse A3 adenosine receptor gene, did not yield speci¢c sig-
nal after 3 weeks of exposure (data not shown). Low levels of
expression would likely preclude detection of signal by in situ
hybridization, which is a far less sensitive method of detection
when compared with the assay for L-galactosidase activity.
Hence, we turned to a more sensitive method for examining
these tissues, involving RT-PCR. RNA was isolated from
several organs, including retina and cerebrospinal vasculature,
of several Sprague^Dawley rats. Subsequent RT-PCR ampli-
¢cation using primers speci¢c for rat A3 adenosine receptor
cDNA showed signi¢cant levels of A3 adenosine receptor
message in both retina and cerebrospinal vasculature, in con-
trast to a very low level of message in other tissues, such as
skeletal muscle. GAPDH message was uniformly high in all
organs examined (Fig. 4).
3.5. L-Galactosidase activity in brains of transgenic mice
Brain A3 adenosine receptor expression has been described
in several species including human, sheep, rat, and mouse [1].
Sites of expression of the A3 adenosine receptor within the
brain have been debated. In a previous study involving in situ
hybridization, we reported A3 adenosine receptor expression
in the thalamus and hypothalamus of the mouse brain, but
not in the cortex and cerebellum [19]. We were interested in
determining the pro¢le of L-galactosidase activity in the brains
of the pSA3Z mice. To this end, brains were dissected, sliced
sagittally and coronally, and stained for L-galactosidase activ-
ity (Fig. 5). Speci¢c staining was detected in brain in all four
transgenic lines. Regions within the thalamus and hypothal-
amus demonstrated speci¢c neuronal staining in more than
one transgenic line (#26s#5s#29=#30). Although the spe-
ci¢c localization in these areas, and the intensity of staining,
was not uniform among the transgenic lines, staining was
consistently present or strong in three of the lines (#26, #5,
#29) in anterior and lateral nuclei of the thalamus, with par-
ticular prominence in the lateral geniculate. In the cerebral
cortex, scattered large neurons in deeper layers exhibited
L-galactosidase activity, and the cerebellum displayed staining
concentrated in its lateral margins. In general, the cortical
staining was signi¢cantly stronger in the #26 line, weaker or
absent in the other lines. In the brainstem, L-galactosidase
staining was present in two lines in the interpeduncular nu-
cleus, and in the associated habenulo-interpeduncular tract
(#26s#5); three lines showed scattered staining of neurons
in the superior colliculus (#5s#26s#29).
4. Discussion
We have examined the in vivo promoter activity of a 2.3 kb
fragment of murine genomic DNA located 5P upstream of the
A3 adenosine receptor coding region by coupling it to the
E. coli lacZ coding region. The pro¢le of L-galactosidase ac-
tivity in transgenic mice generated using this construct was
examined, and locations of speci¢c L-galactosidase activity
were compared with the pattern of expression of the en-
dogenous A3 adenosine receptor gene. Four major sites of
L-galactosidase activity ^ testis, brain, retina, and cerebrospi-
nal vasculature ^ were detected, and analyzed in detail. Two
of these sites, the retina and cerebrospinal vasculature, have
not been previously described as locations of A3 adenosine
receptor expression.
We demonstrated that the pro¢le of L-galactosidase activity
in our transgenic mice is consistent with that described in
previous reports for A3 adenosine receptor mRNA expression
in the testis of the rat. Furthermore, we have demonstrated by
in situ hybridization that the pattern of testicular expression
of the endogenous mouse A3 adenosine receptor gene is con-
sistent with both sets of observations. In the brain, endoge-
nous A3 adenosine receptor and L-galactosidase activity were
detected in the thalamus and hypothalamus. These results
demonstrate that the 2.3 kb promoter used in our studies
can direct transcription in vivo in a tissue- and cell-speci¢c
manner.
We have also demonstrated speci¢c L-galactosidase activity
driven by the murine A3 promoter in sites not previously
connected with endogenous A3 adenosine receptor expression,
speci¢cally in the retina. The consistency of this histochemical
activity in multiple, independent transgenic lines indicates that
the retinal L-galactosidase expression is not an artifact of
transgene insertion site but is instead an accurate re£ection
of the capacity of the 2.3 kb A3 promoter region to direct
tissue-speci¢c transcription. Our RT-PCR analysis suggests
that the activity of this promoter region in the transgene
may be matched by signi¢cant expression of the endogenous
A3 adenosine receptor gene in the rodent retina. A potential
role for the A3 adenosine receptor in the retina has yet to be
explored, but there are several reports describing modulation
of axonal regeneration in cultured retinal ganglion cells by
di¡erent nucleosides, including guanosine, adenosine, and ino-
sine [20^22]. Conversely, the scattered cerebral cortical stain-
ing observed in di¡erent transgenic lines and the cerebellar
staining seen in line #26 were not consistent and could be
the result of a low level of transgene activation dependent
upon the di¡erent sequences surrounding each (random)
genomic insertion point in each of the transgenic lines. Never-
theless, the overall consistency of transgene activity in thala-
mic neurons, together with the match of speci¢c L-galacto-
sidase localization in retinal ganglion cells of three lines,
demonstrates that the A3 promoter region in our transgenic
construct contains elements that direct expression to speci¢c
groups of neurons.
As with the retina, we have shown a potential match of
transgene activity in di¡erent lines with endogenous A3
adenosine receptor expression in smooth muscle cells in blood
vessels around the brain and spinal cord. Our observations
indicated clearly, however, that only a subset of all VSMC
in the cerebrospinal vasculature exhibited L-galactosidase ac-
tivity. This might indicate a mosaic pattern of activation of
the A3 adenosine receptor gene promoter within the vascula-
ture, as observed for the smooth muscle myosin heavy chain
promoter in transgenic mice [23]. In that case, the promoter
region examined was active only in some VSMC in vivo,
suggesting that a larger promoter fragment or an intronic se-
quence might direct high expression in other VSMC. Some
reports have described signi¢cant transcriptional heterogene-
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ity in VSMC [24,25]. A more detailed analysis will be neces-
sary to identify all of the sequences in the vicinity of the A3
adenosine receptor gene that modulate smooth muscle expres-
sion.
It is established that the endogenous A3 adenosine receptor
gene is active in cells of the myeloid lineage, including mast
cells and macrophages [5,26] ; cultures of bone marrow-
derived mast cells show high levels of A3 expression [5]. We
have been unable to detect L-galactosidase activity in perito-
neal mast cells and lung tissue of pSA3Z transgenic mice by
histochemistry (data not shown). RT-PCR analysis of cul-
tured bone marrow-derived mast cells and lung tissue has
also failed to reveal any speci¢c expression of lacZ mRNA
in our transgenic pSA3Z mice. It is possible that the sensitiv-
ity of the methods used may be insu⁄cient to detect low levels
of A3 promoter activity in these locations. An alternative ex-
planation for this observed discrepancy is that sequences not
included in the 2.3 kb fragment used in our construct are
necessary to direct myeloid-speci¢c A3 adenosine receptor ex-
pression. It is plausible that sequence elements that are either
more distant from known transcriptional start sites, or within
introns [27,28], could be required to endow a transgene with
the full transcriptional capacity of the endogenous A3 adeno-
sine receptor gene.
In summary, our transgene faithfully recapitulates cell-
speci¢c expression in testis, and also directs expression to
neurons in the thalamus in the brain, to ganglion cells in
the retina, and to smooth muscle cells in the cerebrospinal
vasculature. We have shown that the latter two sites do, in
fact, express signi¢cant levels of endogenous A3 adenosine
receptor mRNA. Lines #5 and #26 could serve as convenient
models for studying, in vivo, the e¡ect of di¡erent ligands on
the suppression or enhancement of transcriptional activity of
the A3 adenosine receptor gene in the brain, testis, retina, and
cerebrospinal vasculature. In addition, the promoter region
we have characterized may be used to drive the tissue-speci¢c
expression of foreign genes in areas already expressing the
endogenous A3 adenosine receptor, in order to examine po-
tential coregulation.
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